% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Ebert:163659,
author = {N. Ebert$^*$ and A. Kensche$^*$ and S. Löck$^*$ and W. W.
Hadiwikarta$^*$ and A. Hänsch$^*$ and W. Dörr$^*$ and M.
Krause$^*$ and C. Hannig$^*$ and M. Baumann$^*$},
title = {{R}esults of a randomized controlled phase {III} trial:
efficacy of polyphenol-containing cystus® tea mouthwash
solution for the reduction of mucositis in head and neck
cancer patients undergoing external beam radiotherapy.},
journal = {Strahlentherapie und Onkologie},
volume = {197},
number = {1},
issn = {1439-099X},
address = {Heidelberg},
publisher = {Springer Medizin},
reportid = {DKFZ-2020-01936},
pages = {63-73},
year = {2021},
note = {#EA:E220#LA:E220#2021 Jan;197(1):63-73},
abstract = {To determine the effect of Cystus® tea (Naturprodukte Dr.
Pandalis GmbH $\&$ Co. KG) as mouthwash compared to sage tea
on oral mucositis in patients undergoing radio(chemo)therapy
for head and neck cancer.In this randomized, prospective
phase III study, 60 head and neck cancer patients with
primary or postoperative radio(chemo)therapy were included
between 04/2012 and 06/2014. They received either sage or
Cystus® tea for daily mouthwash under therapy. Mucositis
was scored twice a week following the Radiation Therapy
Oncology Group and the European Organization for Research
and Treatment Cancer (RTOG/EORTC) scoring system. Dental
parameters were also recorded. Statistical evaluation of the
primary endpoint was performed using t‑test and log rank
test.Data from 57 patients could be evaluated. Patient
characteristics showed no significant difference between the
two groups (n = 27 sage; n = 30 Cystus®). A total of
55 patients received the prescribed dose (60-66 Gy
postoperative; 70-76.8 Gy primary). Mucositis grade 3 was
observed in 23 patients (n = 11 sage; n = 12 Cystus®)
and occurred between day 16 and 50 after start of therapy.
There was no significant difference between the two groups
in latency (p = 0.75) and frequency (p = 0.85) of the
occurrence of mucositis grade 3. The self-assessment of the
oral mucosa and the tolerability of the tea also showed no
significant differences. Occurrence of dental pathologies
appeared to increase over time after radiotherapy.Cystus®
and sage tea have a similar effect on the occurrence of
radiation-induced mucositis regarding latency and incidence.
Cystus® tea mouthwash solution is tolerated well and can be
applied in addition to intensive oral care and hygiene along
with the application of fluorides.},
cin = {DD01 / E220 / M010},
ddc = {610},
cid = {I:(DE-He78)DD01-20160331 / I:(DE-He78)E220-20160331 /
I:(DE-He78)M010-20160331},
pnm = {315 - Bildgebung und Radioonkologie (POF4-315)},
pid = {G:(DE-HGF)POF4-315},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:32970162},
doi = {10.1007/s00066-020-01684-y},
url = {https://inrepo02.dkfz.de/record/163659},
}